Organization: Health Canada
Year: 2024
Month: November
Request Number: A-2024-000546
Request Summary: Documents showing the most current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a generic liraglutide product, which was accepted into review by Health Canada in November 2023: Inactive; Process; Process Hold; Withdrawn.
Disposition: Disclosed in part
Number of pages: 2